Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study

J Neurol. 2013 Feb;260(2):668-9. doi: 10.1007/s00415-012-6764-3. Epub 2012 Nov 25.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Aminopyridine / therapeutic use*
  • Adult
  • Ataxia / drug therapy*
  • Ataxia / genetics
  • Calcium Channels / genetics
  • Humans
  • Male
  • Middle Aged
  • Nystagmus, Pathologic / drug therapy*
  • Nystagmus, Pathologic / genetics
  • Observation
  • Potassium Channel Blockers / therapeutic use*

Substances

  • CACNA1A protein, human
  • Calcium Channels
  • Potassium Channel Blockers
  • 4-Aminopyridine

Supplementary concepts

  • Episodic Ataxia, Type 2